EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis

Diego Casas Deza iD, Cristina Polo Cuadro, Marta Gascón Ruiz iD, Manuel Barreiro-de Acosta iD, Míriam Mañosa, Francisco Rodríguez-Moranta iD, Yamile Zabana iD, Elena Céspedes Martínez iD, Ingrid Ordás iD, José Miranda Bautista, María José García iD, Irene García de la Filia Molina und 41 weitere

Journal of Clinical Medicine · 02.01.2026 · 15 (1) · 353

DOI: 10.3390/jcm15010353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.01.2026. Verfasst von Diego Casas Deza und 52 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Aparato Digestivo, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón, 50009 Zaragoza, Spain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy. They can cause immune-mediated colitis (IMC), a potentially severe adverse event. Current data on severe IMC (grade 3–4) are limited, particularly regarding clinical, endoscopic, and histological features.

Methods

We conducted a multicenter, retrospective observational study promoted by GETECCU, including adults with solid tumors who developed grade 3–4 IMC requiring hospitalization and systemic therapy. Clinical symptoms, endoscopic findings (Mayo and UCEIS indices), and histological features were systematically collected and analyzed.

Results

A total of 196 patients were included. Diarrhea was universal (median 8 bowel movements/day), with 76% reporting abdominal pain and 39% rectal bleeding. Endoscopy (n = 139) revealed vascular pattern loss (80%), mucosal lesions (69%), and Mayo scores ≥2 in 69%. Histopathology (n = 141) showed abnormalities in 85%, including cryptitis (50%), lymphocytic infiltration (48%), and crypt abscesses (37%). Notably, 72% of patients with normal endoscopy had histological inflammation. Endoscopic severity correlated with bleeding and impaired general condition but not with stool frequency or pain intensity. Histological and endoscopic severity were modestly associated.

Conclusions

Severe IMC presents with heterogeneous clinical, endoscopic, and histological features, with limited correlation between these domains. Endoscopic findings were often ulcerative and inflammatory, yet histological abnormalities were frequently present even in endoscopically inactive disease. These findings highlight the importance of biopsy in all suspected IMC cases and underscore the need for validated multidimensional assessment tools for accurate diagnosis and management of severe IMC.

Schlagwörter

Stichwörter der Autor:innen

endoscopyhistologyimmune checkpoint inhibitorsimmune-mediated colitis

Autor:innen und Institutionen

  • Servicio de Aparato Digestivo, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón, 50009 Zaragoza, Spain.
  • Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón, 50009 Zaragoza, Spain.
  • Servicio de Aparato Digestivo, Hospital Clínico Universitario de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
  • Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Servicio de Aparato Digestivo, Hospital Universitari de Bellvitge, 08907 L'Hospitalet de Llobregat, Spain.
  • CIBERhed, Hospital Universitari Mútua de Terrassa, 08221 Terrassa, Spain.

ORCID-Profile: Diego Casas Deza, Marta Gascón Ruiz, Manuel Barreiro-de Acosta, Francisco Rodríguez-Moranta, Yamile Zabana, Elena Céspedes Martínez, Ingrid Ordás, María José García, Cristina Roig Ramos, José Xavier Segarra-Ortega, Virginia Matallana Royo, Fernando Martínez de Juan, Noemí Manceñido Marcos, Eduard Brunet Mas, Inmaculada Alonso Abreu, Javier Santos Fernández, María Vaamonde Lorenzo, Patricia Sanz Segura, Óscar Moralejo Lozano, Rocío Ferreiro-Iglesias, Pablo Miles Wolfe García, Pere Borras Garriga, María Calvo Iñiguez, Xavier Serra-Ruiz, Luis Menchén, Francisco Mesonero Gismero, Raquel Vicente Lidón, Ana Gutierrez, Santiago García López

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Casas Deza, D., Polo Cuadro, C., Gascón Ruiz, M., Barreiro-de Acosta, M., Mañosa, M., Rodríguez-Moranta, F., Zabana, Y., Céspedes Martínez, E., Ordás, I., Miranda Bautista, J., García, M. J., García de la Filia Molina, I., Roig Ramos, C., Ruiz Cerulla, A., Segarra-Ortega, J. X., Matallana Royo, V., Rodríguez González, E., Martínez de Juan, F., Manceñido Marcos, N., …, & GETECCU (2026). Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis. Journal of Clinical Medicine, 15(1), 353. https://doi.org/10.3390/jcm15010353

Vancouver

Casas Deza D, Polo Cuadro C, Gascón Ruiz M, Barreiro-de Acosta M, Mañosa M, Rodríguez-Moranta F, et al. Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis. Journal of Clinical Medicine. 2026;15(1):353. doi:10.3390/jcm15010353

BibTeX
@article{CasasDeza2026,
  author = {Casas Deza, Diego and Polo Cuadro, Cristina and Gascón Ruiz, Marta and Barreiro-de Acosta, Manuel and Mañosa, Míriam and Rodríguez-Moranta, Francisco and Zabana, Yamile and Céspedes Martínez, Elena and Ordás, Ingrid and Miranda Bautista, José and García, María José and García de la Filia Molina, Irene and Roig Ramos, Cristina and Ruiz Cerulla, Alexandra and Segarra-Ortega, José Xavier and Matallana Royo, Virginia and Rodríguez González, Esther and Martínez de Juan, Fernando and Manceñido Marcos, Noemí and Madero Velázquez, Lucía and Betoré Glaría, Elena and Álvarez Herrero, Begoña and Suris, Gerard and Garrido Marín, Alejandro and Brunet Mas, Eduard and Alonso Abreu, Inmaculada and Santos Fernández, Javier and Vaamonde Lorenzo, María and Almingol Crespo, Cristina and Folguera, Carla and Sanz Segura, Patricia and Moralejo Lozano, Óscar and López Couceiro, Laura and Tejido Sandoval, Coral and Mena Sánchez, Raquel and Sainz, Empar and Marquès-Camí, Miquel and Ferreiro-Iglesias, Rocío and Ortega Moya, Silvia Patricia and Wolfe García, Pablo Miles and Borras Garriga, Pere and Herreros Martínez, Belén and Calvo Iñiguez, María and Frago Larramona, Santiago and Ladrón Abia, Pablo and Serra-Ruiz, Xavier and Menchén, Luis and Rivas Rivas, Coral and Mesonero Gismero, Francisco and Vicente Lidón, Raquel and Gutierrez, Ana and García López, Santiago and GETECCU, GETECCU},
  title = {Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {353},
  doi = {10.3390/jcm15010353}
}
Kostenlos starten →